Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences

Heymann, D. orcid.org/0000-0001-7777-0669 (2012) Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences. Journal of Bone Oncology, 1 (1). pp. 2-11. ISSN 2212-1366

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2012 Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Bone cancer; Bone metastases; Bone sarcomas; Osteoclasts; RANKL; Bone remodeling
Dates:
  • Published: June 2012
  • Published (online): 26 April 2012
  • Accepted: 28 March 2012
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 14 Apr 2016 10:20
Last Modified: 14 Apr 2016 10:20
Published Version: http://dx.doi.org/10.1016/j.jbo.2012.03.001
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jbo.2012.03.001
Related URLs:

Share / Export

Statistics